This article will review the formulation of oral semaglutide that allows for oral administration, discuss recently published efficacy and safety data, and consider the potential role of this novel GLP-1 receptor agonist in patient care
Stupnisek, M., Kokot, A., Drmic, D., Hrelec Patrlj, M., Zenko Sever, A., Kolenc, D.,
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are FDA-approved medications originally developed for diabetes management, now widely used for safe and effective weight loss
The same applies to understanding its testing profile: complete information is always better than partial reassurance